RECRUITING

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty

Official Title

Persona® OsseoTi® Keel Compatibility Study-A Multicenter Cohort Study a Prospective, Post-market Clinical Follow-up Study to Demonstrate Safety, Performance and Clinical Benefits of the Persona Knee System Portfolio and Its Instrumentation

Quick Facts

Study Start:2023-06-28
Study Completion:2035-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05787821

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patient is of legal age and skeletally mature
  2. 2. Patient is willing and able to provide written Informed Consent by signing and dating the Institutional Review Board (IRB) / Ethics Committee (EC) approved Informed Consent document
  3. 3. Patient is willing and able to complete scheduled follow-up evaluations as defined in the study protocol
  4. 4. Independent of study participation, patient qualifies for either cemented or cementless primary or revision total knee arthroplasty (including salvage of previously failed surgical attempts) based upon physical exam and medical history, and meets the approved indications for use of the commercially available Persona Knee System with appropriately matched Zimmer Biomet components implanted in accordance with product labeling
  1. 1. Patient is currently participating in any other surgical intervention or pain management study
  2. 2. Patient is pregnant or considered a member of a protected (vulnerable) population whose inclusion in the study is inappropriate (e.g. prisoner, mentally incompetent)
  3. 3. Patient has a mental or neurological condition who is unwilling or incapable of following postoperative care instructions
  4. 4. Patient has a condition which would, in the judgment of the investigator, place the patient at undue risk or interfere with the conduct of the study
  5. 5. Patient is institutionalized or is a known drug abuser, a known alcoholic or cannot understand the requirements of study participation
  6. 6. Patient is scheduled to undergo simultaneous bilateral total knee arthroplasty
  7. 7. Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint
  8. 8. Insufficient bone stock on femoral or tibial surfaces
  9. 9. Neuropathic arthropathy
  10. 10. Osteoporosis or any loss of musculature or neuromuscular disease that compromises the affected limb
  11. 11. A stable, painless arthrodesis in a satisfactory functional position
  12. 12. Severe instability secondary to the absence of collateral ligament integrity
  13. 13. Rheumatoid Arthritis (RA) accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
  14. 14. Patient has a \> 5˚ valgus deformity with a medial collateral ligament (MCL) insufficiency, and the surgeon intends to use the personalized alignment surgical technique

Contacts and Locations

Study Contact

Erik Kowalski, PhD
CONTACT
6473316652
erik.kowalski@zimmerbiomet.com

Principal Investigator

Hillary Overholser
STUDY_DIRECTOR
Zimmer Biomet

Study Locations (Sites)

Denver Hip & Knee, Inc.
Parker, Colorado, 80138
United States
Foundation for Orthopaedic Research & Education
Tampa, Florida, 33607
United States
Northside Hospital, Inc.
Atlanta, Georgia, 30342
United States
U of L Health
Louisville, Kentucky, 40202
United States
University of Michigan
Ann Arbor, Michigan, 48109
United States
Mayo Clinic
Rochester, Minnesota, 55902
United States
Mississippi Sports Medicine and Orthopaedic Center
Jackson, Mississippi, 39202
United States
New Mexico Orthopaedic Associates
Albuquerque, New Mexico, 87110
United States
Syracuse Orthopaedic Specialists
DeWitt, New York, 13214
United States
NYU
New York, New York, 11016
United States
St. Francis Hospital & Heart Center
Roslyn, New York, 11576
United States
OrthoCarolina Research Institute, Inc.
Charlotte, North Carolina, 28207
United States
Duke University
Morrisville, North Carolina, 27560
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
Southern Joint Replacement Institute
Nashville, Tennessee, 37203
United States
UT Health at Houston
Houston, Texas, 77030
United States
UVA Health Orthopedic Center
Charlottesville, Virginia, 22903
United States

Collaborators and Investigators

Sponsor: Zimmer Biomet

  • Hillary Overholser, STUDY_DIRECTOR, Zimmer Biomet

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-28
Study Completion Date2035-06

Study Record Updates

Study Start Date2023-06-28
Study Completion Date2035-06

Terms related to this study

Keywords Provided by Researchers

  • Osteoarthritis
  • Total Knee Arthroplasty

Additional Relevant MeSH Terms

  • Knee Pain Chronic
  • Osteoarthritis, Knee
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Polyarthritis
  • Varus Deformity
  • Valgus Deformity
  • Flexion Deformity of Knee
  • Avascular Necrosis